Siyi Yu1, Wei Wei1, Liying Liu1, Xiaoli Guo1, Zhifu Shen2, Jin Tian1, Fang Zeng3, Fanrong Liang4, Jie Yang5. 1. Brain Research Center, Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, China. 2. North Sichuan Medical College, Nanchong, China. 3. Brain Research Center, Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, China. zeng_fang@126.com. 4. Brain Research Center, Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, China. acuresearch@126.com. 5. Brain Research Center, Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, 37 Shierqiao Road, Chengdu, China. jenny_yang_jie@126.com.
Abstract
BACKGROUND: Primary dysmenorrhea (PDM) is highly associated with mood symptoms. However, the neuropathology of these comorbidities is unclear. In the present study, we aimed to investigate the structural changes in the amygdala of patients with PDM during the pain-free phase using a surface-based shape analysis. METHODS: Forty-three PDM patients and forty healthy controls were recruited in the study, and all participants underwent structural magnetic resonance imaging scans during their periovulatory phase. FMRIB's Integrated Registration and Segmentation Tool (FIRST) was employed to assess the subcortical volumetric and surface alterations in patients with PDM. Moreover, correlation and mediation analyses were used to detect the clinical significance of the subcortical morphometry alteration. RESULTS: PDM patients showed hypertrophic alteration of the amygdala in the left superficial nuclei and right basolateral and superficial nuclei but not for the whole amygdala volume. The hypertrophic amygdala was associated with disease duration, pain severity and anxiety symptoms during the menstrual period. Furthermore, the hypertrophic left amygdala could mediate the association between disease duration and anxiety severity. CONCLUSIONS: The results of the current study demonstrated that the localized amygdala shape hypertrophy was present in PDM patients even in the pain-free phase. In addition, the mediator role of the hypertrophic amygdala indicates the potential target of amygdala for anxiety treatment in PDM treatment in the pain-free phase.
BACKGROUND: Primary dysmenorrhea (PDM) is highly associated with mood symptoms. However, the neuropathology of these comorbidities is unclear. In the present study, we aimed to investigate the structural changes in the amygdala of patients with PDM during the pain-free phase using a surface-based shape analysis. METHODS: Forty-three PDM patients and forty healthy controls were recruited in the study, and all participants underwent structural magnetic resonance imaging scans during their periovulatory phase. FMRIB's Integrated Registration and Segmentation Tool (FIRST) was employed to assess the subcortical volumetric and surface alterations in patients with PDM. Moreover, correlation and mediation analyses were used to detect the clinical significance of the subcortical morphometry alteration. RESULTS: PDM patients showed hypertrophic alteration of the amygdala in the left superficial nuclei and right basolateral and superficial nuclei but not for the whole amygdala volume. The hypertrophic amygdala was associated with disease duration, pain severity and anxiety symptoms during the menstrual period. Furthermore, the hypertrophic left amygdala could mediate the association between disease duration and anxiety severity. CONCLUSIONS: The results of the current study demonstrated that the localized amygdala shape hypertrophy was present in PDM patients even in the pain-free phase. In addition, the mediator role of the hypertrophic amygdala indicates the potential target of amygdala for anxiety treatment in PDM treatment in the pain-free phase.
Authors: S J A van den Bogaard; E M Dumas; L Ferrarini; J Milles; M A van Buchem; J van der Grond; R A C Roos Journal: J Neurol Sci Date: 2011-05-31 Impact factor: 3.181
Authors: Christian L Seifert; Stefano Magon; Till Sprenger; Undine E Lang; Christian G Huber; Niklaus Denier; Marc Vogel; André Schmidt; Ernst-Wilhelm Radue; Stefan Borgwardt; Marc Walter Journal: Eur Arch Psychiatry Clin Neurosci Date: 2014-12-03 Impact factor: 5.270
Authors: Lorah D Dorn; Sonya Negriff; Bin Huang; Stephanie Pabst; Jennifer Hillman; Paula Braverman; Elizabeth J Susman Journal: J Adolesc Health Date: 2008-10-29 Impact factor: 5.012